Global Yeast Beta-Glucan Market

Yeast Beta-Glucan Market Size, Share, Growth Analysis, By Source(Baker's yeast, brewer's yeast, and others), By Application(food & beverages, dietary supplements, animal feed & pet food, and others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG30I2298 | Region: Global | Published Date: April, 2024
Pages: 198 | Tables: 64 | Figures: 75

Yeast Beta-Glucan Market Competitive Landscape

Global Yeast Beta-Glucan Market is highly competitive with the presence of several key players. These players are focusing on product innovation, partnerships, mergers and acquisitions, and expansion to increase their market share and stay competitive in the market. For instance, in December 2021, Lallemand Inc. entered into a partnership with Biotalys NV, a biotech company, to develop and commercialize new biocontrol solutions for food and beverage applications. Such strategic initiatives are expected to drive the growth of the yeast beta-glucan market in the coming years.

Yeast Beta-Glucan Market Top Player’s Company Profiles

  • Biothera Pharmaceuticals, Inc. (US)
  • Kerry Group plc (Ireland)
  • AB Mauri (UK)
  • Biotec Pharmacon ASA (Norway)
  • Angel Yeast Co., Ltd. (China)
  • Garuda International, Inc. (US)
  • Ceapro Inc. (Canada)
  • Kemin Industries, Inc. (US)
  • Leiber GmbH (Germany)
  • Nutraferma LLC (US)
  • Merck KGaA (Germany)
  • Biorigin (Brazil)
  • Lianhua Supermarket Holdings Co., Ltd. (China)
  • Alltech, Inc. (US)
  • Royal DSM N.V. (Netherlands)
  • Chr. Hansen Holding A/S (Denmark)
  • Kerry Ingredients & Flavors (US)

Yeast Beta-Glucan Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Yeast Beta-Glucan Market size was valued at USD 188.66 million in 2022 and is poised to grow from USD 204.32 million in 2023 to USD 386.67 million by 2031, at a CAGR of 8.3% during the forecast period (2024-2031).

Yeast Beta-Glucan Market is highly competitive with the presence of several key players. These players are focusing on product innovation, partnerships, mergers and acquisitions, and expansion to increase their market share and stay competitive in the market. For instance, in December 2021, Lallemand Inc. entered into a partnership with Biotalys NV, a biotech company, to develop and commercialize new biocontrol solutions for food and beverage applications. Such strategic initiatives are expected to drive the growth of the yeast beta-glucan market in the coming years. 'Lesaffre Group (France)', 'Lallemand Inc. (Canada)', 'Ohly GmbH (Germany)', 'Biothera Pharmaceuticals, Inc. (US)', 'Kerry Group plc (Ireland)', 'AB Mauri (UK)', 'Biotec Pharmacon ASA (Norway)', 'Angel Yeast Co., Ltd. (China)', 'Garuda International, Inc. (US)', 'Ceapro Inc. (Canada)', 'Kemin Industries, Inc. (US)', 'Leiber GmbH (Germany)', 'Nutraferma LLC (US)', 'Merck KGaA (Germany)', 'Biorigin (Brazil)', 'Lianhua Supermarket Holdings Co., Ltd. (China)', 'Alltech, Inc. (US)', 'Royal DSM N.V. (Netherlands)', 'Chr. Hansen Holding A/S (Denmark)', 'Kerry Ingredients & Flavors (US)'

One of the key drivers of the yeast beta-glucan market is the increasing demand for natural and organic food products. Consumers are becoming more health-conscious and are looking for natural and effective ways to improve their health. Yeast beta-glucan is a natural ingredient that is effective in promoting health and wellness, making it a popular choice among consumers. For instance, in 2020, Kellogg Company, an American multinational food manufacturing company, launched a new line of cereals containing beta-glucan sourced from oats and barley to meet the growing demand for natural and healthy food products.

Growing Trend of Plant-Based Diets: The growing trend of plant-based diets is driving the growth of the yeast beta-glucan market. Consumers are becoming more health-conscious and are opting for plant-based diets due to the health and environmental benefits associated with them. Yeast beta-glucan is a natural and plant-based ingredient, making it a popular choice among consumers who are following plant-based diets.

The yeast beta-glucan market is dominated by North America, which is expected to hold a 35% share of the market in the coming years. This dominance is attributed to the increasing demand for natural and functional food ingredients, along with the rising health consciousness among consumers in the region. The United States is a major contributor to the growth of the yeast beta-glucan market in North America. The country has a large population of health-conscious consumers who are willing to pay a premium for natural and effective health solutions. For instance, companies like Biothera Pharmaceuticals, Inc. have developed and launched yeast beta-glucan-based dietary supplements in the US market, which has received a positive response from consumers.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Yeast Beta-Glucan Market

Report ID: SQMIG30I2298

$5,300
BUY NOW GET FREE SAMPLE